117 related articles for article (PubMed ID: 15635641)
1. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors.
Jenssen H; Gutteberg TJ; Lejon T
J Pept Sci; 2005 Feb; 11(2):97-103. PubMed ID: 15635641
[TBL] [Abstract][Full Text] [Related]
2. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate.
Jenssen H; Andersen JH; Uhlin-Hansen L; Gutteberg TJ; Rekdal Ø
Antiviral Res; 2004 Feb; 61(2):101-9. PubMed ID: 14670583
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
4. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
6. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
7. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors.
Lejon T; Strøm MB; Svendsen JS
J Pept Sci; 2001 Feb; 7(2):74-81. PubMed ID: 11277499
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
[TBL] [Abstract][Full Text] [Related]
10. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
Trybala E; Olofsson S; Mårdberg K; Svennerholm B; Umemoto K; Glorioso JC; Bergström T
Antiviral Res; 2004 Jun; 62(3):125-34. PubMed ID: 15130536
[TBL] [Abstract][Full Text] [Related]
12. Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity.
Mårdberg K; Nyström K; Tarp MA; Trybala E; Clausen H; Bergström T; Olofsson S
Glycobiology; 2004 Jul; 14(7):571-81. PubMed ID: 15044392
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
Marchetti M; Ammendolia MG; Superti F
Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
[TBL] [Abstract][Full Text] [Related]
14. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
Lejon T; Stiberg T; Strøm MB; Svendsen JS
J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
[TBL] [Abstract][Full Text] [Related]
15. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
18. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
Jenssen H
Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2.
Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML
Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304
[TBL] [Abstract][Full Text] [Related]
20. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]